Papers: 10.3389/fonc.2021.638295

https://doi.org/10.3389/fonc.2021.638295

Efficacy and Safety of PARP Inhibitor Combination Therapy in Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis

Cited by: 5
Author(s): Ning Ren, Leyin Zhang, Jinping Yu, Siqi Guan, Xinyang Dai, Leitao Sun, Ying Min-li
Published: about 5 years ago

Software Mentions 1